% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Vanasse:845582,
author = {Vanasse, Thomas J. and Fox, P. Mickle and Barron, Daniel S.
and Robertson, Michaela and Eickhoff, Simon and Lancaster,
Jack L. and Fox, Peter T.},
title = {{B}rain{M}ap {VBM}: {A}n environment for structural
meta-analysis},
journal = {Human brain mapping},
volume = {39},
number = {8},
issn = {1065-9471},
address = {New York, NY},
publisher = {Wiley-Liss},
reportid = {FZJ-2018-02807},
pages = {3308-3325},
year = {2018},
note = {National Institutes of Health, Grant/AwardNumbers: MH74457,
RR024387,MH084812, NS062254, AA019691,EB015314;
Congressionally DirectedMedical Research Program,
Grant/AwardNumbers: W81XWH0820112,W81XWH1410316; Department
ofDefense, Grant/Award Number:W81XWH1320065},
abstract = {The BrainMap database is a community resource that curates
peer-reviewed, coordinate-based human neuroimaging
literature. By pairing the results of neuroimaging studies
with their relevant meta-data, BrainMap facilitates
coordinate-based meta-analysis (CBMA) of the neuroimaging
literature en masse or at the level of experimental
paradigm, clinical disease, or anatomic location. Initially
dedicated to the functional, task-activation literature,
BrainMap is now expanding to include voxel-based morphometry
(VBM) studies in a separate sector, titled: BrainMap VBM.
VBM is a whole-brain, voxel-wise method that measures
significant structural differences between or within groups
which are reported as standardized, peak x-y-z coordinates.
Here we describe BrainMap VBM, including the meta-data
structure, current data volume, and automated reverse
inference functions (region-to-disease profile) of this new
community resource. CBMA offers a robust methodology for
retaining true-positive and excluding false-positive
findings across studies in the VBM literature. As with
BrainMap's functional database, BrainMap VBM may be
synthesized en masse or at the level of clinical disease or
anatomic location. As a use-case scenario for BrainMap VBM,
we illustrate a trans-diagnostic data-mining procedure
wherein we explore the underlying network structure of 2,002
experiments representing over 53,000 subjects through
independent components analysis (ICA). To reduce
data-redundancy effects inherent to any database, we
demonstrate two data-filtering approaches that proved
helpful to ICA. Finally, we apply hierarchical clustering
analysis (HCA) to measure network- and disease-specificity.
This procedure distinguished psychiatric from neurological
diseases. We invite the neuroscientific community to further
exploit BrainMap VBM with other modeling approaches.},
cin = {INM-7},
ddc = {610},
cid = {I:(DE-Juel1)INM-7-20090406},
pnm = {574 - Theory, modelling and simulation (POF3-574)},
pid = {G:(DE-HGF)POF3-574},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29717540},
UT = {WOS:000438666800016},
doi = {10.1002/hbm.24078},
url = {https://juser.fz-juelich.de/record/845582},
}